Clinical trial
Prospective Multicenter Phase II Study of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adult Patients With Hematologic Malignancies
NCT02385955 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Multicenter Phase II Study of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adult Patients With Hematologic Malignancies
- Lead sponsor
- Seoul National University Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- April 30, 2015
- Completion date
- April 30, 2019
- Enrollment
- 39 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hematologic malignancy